PA
VERA icon

Profund Advisors’s Vera Therapeutics VERA Stock Holding History

Profund Advisors’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.59M Sell
37,062
-8,410
-18% -$313K 0.04% 252
2026
Q1 		$1.83M Buy
45,472
+13,448
+42% +$579K 0.07% 228
2025
Q4 		$1.62M Buy
32,024
+13,032
+69% +$463K 0.05% 258
2025
Q3 		$552K Buy
18,992
+3,711
+24% +$85.8K 0.02% 480
2025
Q2 		$360K Sell
15,281
-2,362
-13% -$53.1K 0.01% 593
2025
Q1 		$424K Buy
17,643
+552
+3% +$17.7K 0.02% 530
2024
Q4 		$723K Buy
17,091
+1,345
+9% +$59.6K 0.03% 370
2024
Q3 		$696K Sell
15,746
-6,650
-30% -$252K 0.03% 417
2024
Q2 		$810K Sell
22,396
-4,950
-18% -$196K 0.03% 357
2024
Q1 		$1.18M Sell
27,346
-423
-2% -$15.1K 0.05% 319
2023
Q4 		$427K Buy
27,769
+4,655
+20% +$59.1K 0.02% 597
2023
Q3 		$317K Buy
+23,114
New +$397K 0.02% 643

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Profund Advisors's VERA Position: Q2 2026 in Review

Profund Advisors reduced its Vera Therapeutics (VERA) stake by 18% in Q2 2026, selling an estimated $313K and leaving 37,062 shares worth $1.59M. The position accounts for 0.04% of the portfolio, ranked #252.

Profund Advisors first reported a position in VERA in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.83M in Q1 2026. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Profund Advisors held 37,062 shares of Vera Therapeutics worth $1.59M as of Q2 2026.
  • Profund Advisors sold 8,410 Vera Therapeutics shares in Q2 2026, an estimated $313K.
  • Vera Therapeutics made up 0.04% of Profund Advisors's portfolio in Q2 2026, its #252 holding.
  • Profund Advisors first reported a position in Vera Therapeutics in Q3 2023 and has held it in 12 quarters since.
  • Profund Advisors's Vera Therapeutics position peaked at $1.83M in Q1 2026.
  • 220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.